Union Square Park Partners, LP 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:01 am Purchase | 2024-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Union Square Park Partners, LP | 1,485,677 11.440% | 164,292 (+12.43%) | Filing |
| 2024-10-31 1:36 pm Purchase | 2024-10-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Union Square Park Partners, LP | 1,321,385 10.170% | 129,895 (+10.90%) | Filing |
| 2024-10-08 12:42 pm Purchase | 2024-10-03 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Union Square Park Partners, LP | 1,191,490 9.170% | 1,191,490 (New Position) | Filing |